Therapeutic Innovation

The enormous cost caused by mental illnesses is due to the high incidence and chronicity of some of them, as well as to the low efficacy of the drugs used for their treatment. The Therapeutic Innovation programme is a transversal programme with high quality and international visibility and channels CIBERSAM's efforts in the identification of new targets and therapeutic strategies in order to improve existing treatments. The programme integrates basic and clinical groups and develops translational and back-translational research, also working on the improvement of experimental models of mental illness. The programme has a long tradition in the identification and development of new therapeutic strategies, both pharmacological and non-pharmacological.

Lines of research

• Study of the mechanism of action of drugs active in the Central Nervous System. Identification of new therapeutic targets.
• Design and evaluation of new pharmacological and non-pharmacological treatment strategies.
• Study of the physiopathology of psychiatric diseases, including genetic bases.
• Design of new diagnostic and therapeutic tools in experimental models of mental illness.
• Study of the neurobiological bases of resistance to treatments and the mechanism of action of new therapeutic strategies.

Groups